12:00 AM
Jan 11, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Fludase: Phase II started

NexBio began a double-blind, placebo-controlled, U.S. and Mexican Phase II trial to evaluate 2 doses of intranasal DAS181...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >